Astrana Health, Inc. (ASTH)

Astrana Health Financials Overview

Financials in millions USD. Fiscal year is January - December.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue Revenue Growth	972.52	3,182	2,035	1,387	1,144	773.92
Revenue Growth	-59.80%	56.39%	46.72%	21.19%	47.84%	12.62%
Gross Profit Gross Profit Growth	-2,470	341.53	271.39	214.96	199.48	177.77
Operating Income Operating Income Growth	100.46	78.53	89.35	84.61	104.27	98.18
Net Income Net Income Growth	40.55	22.49	43.15	60.72	45.17	68.92
Earnings Per Share EPS Growth	0.82	0.46	0.90	1.29	0.99	1.52
EPS Growth	57.69%	-48.89%	-30.23%	30.30%	-34.87%	50.50%

Revenue by Segment

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Care Delivery Care Delivery Growth	-	250.74	136.67	117.94	95.78	46.69
Intersegment Elimination Intersegment Elimination Growth	-	-338.24	-206.61	-152.12	-124.26	-90.54
Care Partners Care Partners Growth	3,633	3,023	1,949	1,284	1,051	709.71
Care Enablement Care Enablement Growth	-	246.66	155.45	135.82	120.2	107.69
Total Total Growth	3,887	3,182	2,035	1,387	1,144	773.92

Cash & Debt

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Investments Cash & Investments Growth	400.79	429.47	288.46	296.31	293.59	286.51
Total Debt Total Debt Growth	979.41	1,078	470.68	321.01	229.36	200.98
Net Cash (Debt) Net Cash Growth	-578.62	-648.66	-182.22	-24.71	64.23	85.53
Net Cash Growth	-	-	-	-	-24.90%	13921.48%
Net Cash Per Share Net Cash Per Share Growth	-11.70	-13.14	-3.80	-0.53	1.41	1.88

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Operating Cash Flow Operating Cash Flow Growth	107.87	114.6	52.2	68.23	82.13	70.34
Capital Expenditures CapEx Growth	-13.49	-10.11	-8.03	-28.53	-22.94	-19.22
Free Cash Flow Free Cash Flow Growth	94.38	104.49	44.17	39.7	59.19	51.11
Free Cash Flow Growth	-22.16%	136.58%	11.26%	-32.93%	15.80%	13.58%

Margins

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Gross Margin	-253.95%	10.73%	13.34%	15.50%	17.43%	22.97%
Operating Margin	10.33%	2.47%	4.39%	6.10%	9.11%	12.69%
Pretax Margin	6.18%	1.24%	3.97%	6.48%	7.57%	10.05%
Profit Margin	4.03%	0.76%	2.45%	4.17%	4.00%	5.95%
FCF Margin	9.70%	3.28%	2.17%	2.86%	5.17%	6.60%

Valuation

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 11, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
PE Ratio	45.70	53.93	35.03	29.69	29.89	48.34
Forward PE	22.84	29.95	25.02	30.62	65.76	63.35
P/FCF Ratio	19.54	11.61	34.22	45.19	23.28	64.16
PS Ratio	0.48	0.38	0.74	1.29	1.20	4.24

Data Sources: Fiscal.ai and S&P Global Market Intelligence Last updated: Aug 10, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company. Revenue segment data is provided by S&P Global Market Intelligence.

Update frequency:

Quarterly

Last checked:

Aug 11, 2026

Data Sources Report a data error